Public annual accounts

Medifacts financials

A multi-period view of the public annual-account figures reported for Medifacts, with comparable measures and links to available source documents.

Company overview
Registry number

0806713564

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€74,809

+830.1%

EBITDA
€73,869

+1,053.4%

Total assets
€1,073,652

-2.3%

Equity
€44,188

+15.7%

EBITDA margin +98.7% · Equity ratio +4.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202530 Jun 2025€74,809€73,869€1,073,652€44,188-
202430 Jun 2024€8,043€6,405€1,099,065€38,183-
Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report